As a specialized CDMO partner, we integrate vector engineering with phase-appropriate CMC development under the umbrella of Pharmaceutical Development & Manufacturing → Drug Substance Development. We focus on rigorous, laboratory-based biotechnology workflows that turn early vector concepts into robust, scalable, and quality-anchored modalities suitable for downstream manufacturing pathways.
Overview of Gene Therapy Vector
Gene therapy vectors are engineered delivery vehicles that transport defined nucleic-acid cargos into target cells. They can be viral—leveraging evolved capsids and protein machinery—or non-viral—using synthetic carriers such as lipid nanoparticles and plasmid backbones. The field emphasizes payload integrity, controllable expression, biodistribution surrogates, and platform repeatability. A mature vector program balances sequence design, encapsulation chemistry, and analytical orthogonality to ensure stability, potency surrogates, and manufacturability. Modern development therefore couples rational capsid or carrier selection with structure-function optimization, quality attributes definition, and harmonized release-like analytics, enabling smooth progression from benchtop feasibility to formal process characterization.
Our Services
We deliver an integrated portfolio that spans viral and non-viral vectors. Programs begin with design-for-manufacturability principles, multi-parameter analytics, and platform risk mapping, then proceed through iterative optimization cycles.
We offer end-to-end gene therapy vector research and development that unites platform-based strategy, deep analytical expertise, and processes designed with scale and manufacturability in mind. Our integrated laboratory programs span the full development lifecycle, enabling a seamless transition from early concept through well-defined, development-ready vectors.
Across viral platforms such as AAV, lentiviral, and adenoviral systems—as well as non-viral modalities including LNP delivery systems and plasmid DNA foundations—we apply rational design, process optimization, and fit-for-purpose analytics to anchor quality from the outset. The result is a well-characterized, scalable vector system supported by data suitable for informed decision-making and downstream advancement. Contact us to plan your next development milestone and define a clear, efficient path forward.
Our products and services are for research use only.
